Vanderwall, Dana E <br/><br/>
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.  [electronic resource] 

 -  Drug discovery today  Aug 2011 
 - 646-53 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-5832 
<br/><br/><label>Standard No.: </label>10.1016/j.drudis.2011.05.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Databases, Factual<br/>Drug Design<br/>Drug Discovery--methods<br/>Drug Evaluation, Preclinical--methods<br/>Drug Industry--methods<br/>Drug-Related Side Effects and Adverse Reactions<br/>Humans<br/>Pharmaceutical Preparations--chemistry<br/>Risk Assessment--methods<br/>Toxicology--methods